From Data-Driven Medicine

Implications for Behavioral and Social Research of Preclinical Markers of Alzheimer’s Disease and Related Dementias: Proceedings of a Workshop—in Brief

Richard was an invited contributor to NASEM workshop on Implications for Behavioral and Social Research of Preclinical Markers of Alzheimer's Disease and Related Dementias

CATALOGUED UNDER:
Project: Data-Driven MedicineType: Impact on PolicyContributor: Richard Milne

Implications for Behavioral and Social Research of Preclinical Markers of Alzheimer’s Disease and Related Dementias: Proceedings of a Workshop—in Brief

1st September 2021

Excerpt

On June 28-29, 2021, the National Academies of Sciences, Engineering, and Medicine held a virtual workshop, “Behavioral and Social Research and Clinical Practice Implications of Biomarkers and Other Preclinical Diagnostics of Alzheimer’s Disease (AD) and AD-Related Dementias” (AD/ADRD). The workshop was sponsored by the National Institute on Aging with the primary objective to engage in meaningful discussions about the implications of biomarkers and other preclinical diagnostics of AD and ADRD and to generate ideas for future research that might be of interest to the NIA. This publication summarizes the presentation and discussion of the workshop.

Related Link:

Citation:

Implications for Behavioral and Social Research of Preclinical Markers of Alzheimer’s Disease and Related Dementias: Proceedings of a Workshop—in Brief (2021) National Academies of Sciences, Engineering, and Medicine